News

eFuture had signed multiple contracts with Beijing Jingxinlong in 2010, covering end-to-end logistics management solutions. The pharmaceutical distributor is said to have selected eFuture for its logistics IT

The clinical holds placed on the trial were based on an initial review by FDA of the interim results of a long-term rat inhalation carcinogenicity study reported to

According to the deal, BeiGene will in-license intetumumab (CNTO-95) for clinical development and commercialization within Australia, China, Hong Kong, New Zealand, Korea, Singapore and Taiwan. Intetumumab is a

The combined company will have its presence established in more than 60 countries and generated nearly $20bn revenues on a pro-forma basis for the twelve months ended June

The complete EHR is 2011/2012 compliant and has been certified by Drummond Group, an ONC-ATCB, in accordance with the applicable certification criteria adopted by the Secretary of Health

The company is a part of the EU-funded project SEtTReND (Schistosoma Epigenetics – Targets, Regulation, New Drugs) with major focus on drug discovery, dddmag.com reported. The project involves

As per the license agreenent signed between the two companies in 2004 agreement, they will share all data and associated know-how of the MN-221 development program. MN-221 is

The lawsuit was registered for submission of an abbreviated new drug application (ANDA) to the US Food and Drug Administration’s (FDA) prior to the expiration of Noven’s patents

Humana’s experience in health care and Pfizer’s expertise in researching and developing medicines will bring together data and scientific information to better understand patient needs and the effectiveness